Nasus Pharma names Brendan O'Grady as new CEO

Go back to Nasus Pharma names Brendan O'Grady as new CEO
(NASDAQ: ASRT) Delayed: 23.50 --0 (-0%)
Previous Close $23.50    52 Week High $ 
Open $23.50    52 Week Low $ 
Day High $23.50    P/E N/A 
Day Low $23.50    EPS $ 
Volume 2,857       

(NYSE: NSRX) Delayed: 3.84 --0 (-0%)
Previous Close $3.84    52 Week High $ 
Open $3.84    52 Week Low $ 
Day High $3.84    P/E N/A 
Day Low $3.84    EPS $ 
Volume 252